The possibility of obtaining marketing authorization of orphan pharmaceutical compounding preparations: 3,4-DAP for Lambert-Eaton Myasthenic Syndrome
de Wilde, Sofieke, de Jong, Maria G.H., Lipka, Alexander F., Guchelaar, Henk-Jan, Schimmel, Kirsten J.M.Мова:
english
Журнал:
European Journal of Pharmaceutical Sciences
DOI:
10.1016/j.ejps.2017.11.025
Date:
November, 2017
Файл:
PDF, 966 KB
english, 2017
File converter
Більше результатів пошуку
More benefits 
